Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | EVP, HealthCare Enterprises | May 07, 2021 | May 11, 2021 |
| agilon health, inc.AGL · Entity 4698 | Chief Financial Officer | July 01, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date May 07, 2021 · Filed May 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 454,549 |
Reported balance
After 2021-05-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-05-07 · Sale · Disposed 18,000 · Balance 454,549 F1: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 9, 2021. F2: The weighted average price for this transaction is reported within the form. Full information regarding the number of shares at each price is available upon request. F3: Ownership includes 250,001 shares of restricted stock subject to vesting requirements. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 9, 2021.
F2: The weighted average price for this transaction is reported within the form. Full information regarding the number of shares at each price is available upon request.
F3: Ownership includes 250,001 shares of restricted stock subject to vesting requirements.
agilon health, inc.
Report date July 01, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 138,031 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Tax withholding · Disposed 2,311 · Balance 138,031 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F2: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 22:44 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 2,311 | $111.74 | $258,231.14 |
DisclosureSEC source: 0001628280-26-047075 · wk-form4_1783032260.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,031 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:40 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023770 · wk-form4_1775259626.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,342 F3 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. F4 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 23:40 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 1,662 | $9.75 | $16,204.50 |
DisclosureSEC source: 0001628280-26-023770 · wk-form4_1775259626.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,342 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Read SEC document |
| January 10, 2026 Filed Jan 13, 2026 21:44 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-001979 · wk-form4_1768340693.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,675,122 F1 · shares: Restricted stock units that vest in three equal installments on each anniversary of January 10, 2026. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 20:08 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 46,099 | $2.38 | $109,715.62 |
DisclosureSEC source: 0001628280-25-034227 · wk-form4_1751573295.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,075,122 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 28, 2025 Filed May 31, 2025 00:11 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 9,331 | $2.35 | $21,927.85 |
DisclosureSEC source: 0001628280-25-028723 · wk-form4_1748650244.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,121,221 F1 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:40 UTC Amendment | agilon health, inc. AGL · Entity 4698 | GrantOptions (Right to buy) · Derivative | 673,077 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001628280-25-016684 · wk-form4a_1743723619.xml · derivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,077 Underlying: Common Stock · 673,077 shares Expires 2035-04-01 F6 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:40 UTC Amendment | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 428,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016684 · wk-form4a_1743723619.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130,552 F3 · shares: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. F4 · balance_after: Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. F5 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 239,072 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001628280-24-031204 · wk-form4_1720047388.xml · derivative · entry 4 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,072 Underlying: Common Stock · 239,072 shares Expires 2034-07-01 F5 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of July 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 150,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-031204 · wk-form4_1720047388.xml · nonDerivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 723,930 F4 · shares: Performance Stock Units may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 131,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-031204 · wk-form4_1720047388.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 573,100 F3 · shares: Restricted stock units that vest in four equal installments on each anniversary of July 1, 2024. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:56 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 377,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-031204 · wk-form4_1720047388.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,124 F1 · shares: Restricted stock units that vest in three equal installments on each anniversary of July 1, 2024. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 29, 2024 Filed Jun 1, 2024 00:55 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 32,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026125 · wk-form4_1717203327.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,050 F1 · shares: Restricted stock units that vest in full on May 29, 2025, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 29, 2023 Filed Nov 30, 2023 22:04 UTC | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 22,300 | $11.22 | $250,206.00 |
DisclosureSEC source: 0001628280-23-040361 · wk-form4_1701381884.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,931 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 29, 2023 Filed Apr 3, 2025 23:40 UTC Amendment | agilon health, inc. AGL · Entity 4698 | PurchaseCommon Stock | 22,300 | $11.22 | $250,206.00 |
DisclosureSEC source: 0001628280-25-016684 · wk-form4a_1743723619.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 22,300 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · ownership.nature: This transaction was originally reported in November 2023 and is hereby amended to clarify that the shares were purchased by and are held in the Schwaneke Family Joint Spousal Trust. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:49 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 5,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024677 · doc4.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,631 F1 · shares: Restricted stock units that vest in full on April 14, 2024, subject to continued service as a director. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:35 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 9,680 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001209191-22-045617 · doc4.xml · derivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,680 Underlying: Common Stock · 9,680 shares Expires 2032-08-10 F2 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of August 10, 2022, subject to continued service as a director. F2 · derivative.expiration_date: Options that vest in three equal installments on each anniversary of August 10, 2022, subject to continued service as a director. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:35 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 4,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045617 · doc4.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 F1 · shares: Restricted stock units that vest in full on August 10, 2023, subject to continued service as a director. Read SEC document |
| May 07, 2021 Filed May 11, 2021 22:59 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 18,000 | $69.00 | $1,242,000.00 |
DisclosureSEC source: 0001071739-21-000142 · wf-form4_162077397889411.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, HealthCare Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,549 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on March 9, 2021. F2 · price: The weighted average price for this transaction is reported within the form. Full information regarding the number of shares at each price is available upon request. F3 · balance_after: Ownership includes 250,001 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 29, 2020 Filed Feb 12, 2021 23:18 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 2,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-21-000031 · wf-form5_161317187526189.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,549 F1 · balance_after: Ownership includes 250,001 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:31 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 90,000 | $59.73 | $5,375,700.00 |
DisclosureSEC source: 0001071739-20-000274 · wf-form4_160825147522541.xml · nonDerivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,699 F3 · balance_after: Ownership includes this award of 90,000 restricted stock units. 54,000 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 36,000 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 160,001 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:31 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 24,778 | $59.73 | $1,479,989.94 |
DisclosureSEC source: 0001071739-20-000274 · wf-form4_160825147522541.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,699 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:31 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 19,368 | $49.85 | $965,494.80 |
DisclosureSEC source: 0001071739-20-000274 · wf-form4_160825147522541.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,477 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from December 2017 with a three-year performance period. Refer to Form 4 filed on December 14, 2017. 36,000 shares were reported based on achievement of target level of performance. Read SEC document |
| December 12, 2020 Filed Dec 15, 2020 01:02 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 3,581 | $60.71 | $217,402.51 |
DisclosureSEC source: 0001071739-20-000255 · wf-form4_160799414401000.xml · nonDerivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,109 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 196,001 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 01:02 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 5,967 | $61.31 | $365,836.77 |
DisclosureSEC source: 0001071739-20-000255 · wf-form4_160799414401000.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,690 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. Read SEC document |
| December 10, 2020 Filed Dec 15, 2020 01:02 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 5,967 | $63.45 | $378,606.15 |
DisclosureSEC source: 0001071739-20-000255 · wf-form4_160799414401000.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,657 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 22:45 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 7,500 | $68.00 | $510,000.00 |
DisclosureSEC source: 0001071739-20-000114 · wf-form4_158655870228152.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,624 F2 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on February 6, 2020. F1 · balance_after: Ownership includes 230,668 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 12, 2020 Filed Apr 10, 2020 22:45 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-20-000114 · wf-form4_158655870228152.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,124 F1 · balance_after: Ownership includes 230,668 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 00:33 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 33,957 | $62.88 | $2,135,216.16 |
DisclosureSEC source: 0001071739-20-000046 · wf-form4_158103558649005.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,124 F3 · shares: Shares withheld for taxes upon vesting of stock grant. F2 · balance_after: Ownership includes 230,668 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 00:33 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 27,840 | $28.13 | $783,139.20 |
DisclosureSEC source: 0001071739-20-000046 · wf-form4_158103558649005.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,081 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from December 2016 with a three-year performance period. Refer to Form 4 filed on December 15, 2016. 48,000 shares were reported based on achievement of target level of performance. F2 · balance_after: Ownership includes 230,668 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 13, 2019 Filed Dec 14, 2019 00:16 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 4,774 | $58.52 | $279,374.48 |
DisclosureSEC source: 0001071739-19-000185 · wf-form4_157628258817873.xml · nonDerivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,241 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 278,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 12, 2019 Filed Dec 14, 2019 00:16 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 3,580 | $58.64 | $209,931.20 |
DisclosureSEC source: 0001071739-19-000185 · wf-form4_157628258817873.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,015 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 278,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 11, 2019 Filed Dec 14, 2019 00:16 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 5,967 | $59.62 | $355,752.54 |
DisclosureSEC source: 0001071739-19-000185 · wf-form4_157628258817873.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 428,595 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 278,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 10, 2019 Filed Dec 13, 2019 02:28 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 100,000 | $59.17 | $5,917,000.00 |
DisclosureSEC source: 0001071739-19-000164 · wf-form4_157620410585371.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,562 F1 · balance_after: Ownership includes this award of 100,000 restricted stock units. 60,000 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 40,000 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 210,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 23:47 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 26,718 | $64.99 | $1,736,402.82 |
DisclosureSEC source: 0001071739-19-000027 · wf-form4_154958326005588.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,562 F2 · balance_after: Ownership includes 210,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 23:47 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 19,600 | $28.40 | $556,640.00 |
DisclosureSEC source: 0001071739-19-000027 · wf-form4_154958326005588.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,280 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from December 2015 with a three-year performance period. Refer to Form 4 filed on December 17, 2015. 40,000 shares were reported based on achievement of target level of performance. F2 · balance_after: Ownership includes 210,668 shares of restricted stock units subject to vesting requirements. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 22:40 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 4,000 | $125.00 | $500,000.00 |
DisclosureSEC source: 0001071739-19-000011 · wf-form4_154776481148705.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,840 F1 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on November 9, 2018. F2 · balance_after: Ownership includes 125,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 15, 2018 Filed Dec 19, 2018 01:43 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 3,017 | $127.53 | $384,758.01 |
DisclosureSEC source: 0001071739-18-000153 · wf-form4_154518377878268.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,840 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 125,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 22:14 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,414 | $134.29 | $324,176.06 |
DisclosureSEC source: 0001071739-18-000143 · wf-form4_154482565409331.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,857 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 132,001 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 22:14 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 1,811 | $132.83 | $240,555.13 |
DisclosureSEC source: 0001071739-18-000143 · wf-form4_154482565409331.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,271 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 132,001 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 11, 2018 Filed Dec 14, 2018 00:14 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 50,000 | $132.46 | $6,623,000.00 |
DisclosureSEC source: 0001071739-18-000131 · wf-form4_154474643472642.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,082 F2 · balance_after: Ownership includes this award of 50,000 restricted stock units. 30,000 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 20,000 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 91,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| August 14, 2018 Filed Dec 14, 2018 00:14 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-18-000131 · wf-form4_154474643472642.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,082 F1 · balance_after: Ownership includes 91,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 20, 2017 Filed Feb 12, 2018 23:22 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-18-000025 · wf-form5_151847770855028.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,232 F1 · balance_after: Ownership includes 91,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:55 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 3,197 | $99.02 | $316,566.94 |
DisclosureSEC source: 0001071739-17-000117 · wf-form4_151372410947821.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,632 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 91,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 00:14 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,558 | $100.86 | $257,999.88 |
DisclosureSEC source: 0001071739-17-000111 · wf-form4_151329687240936.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,829 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F1 · balance_after: Ownership includes this award of 30,000 restricted stock units. 18,000 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 12,000 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 68,001 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 12, 2017 Filed Dec 15, 2017 00:14 UTC | CENTENE CORP CNC · Entity 3133 | GrantCommon Stock | 30,000 | $99.70 | $2,991,000.00 |
DisclosureSEC source: 0001071739-17-000111 · wf-form4_151329687240936.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,387 F1 · balance_after: Ownership includes this award of 30,000 restricted stock units. 18,000 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 12,000 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 68,001 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 09, 2017 Filed Dec 12, 2017 01:07 UTC | CENTENE CORP CNC · Entity 3133 | Tax withholdingCommon Stock | 2,398 | $101.34 | $243,013.32 |
DisclosureSEC source: 0001071739-17-000100 · wf-form4_151304081793748.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,387 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F1 · balance_after: Ownership includes 73,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| April 26, 2017 Filed Dec 12, 2017 01:07 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-17-000100 · wf-form4_151304081793748.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,785 F1 · balance_after: Ownership includes 73,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 22:33 UTC | CENTENE CORP CNC · Entity 3133 | SaleCommon Stock | 2,000 | $68.52 | $137,040.00 |
DisclosureSEC source: 0001071739-17-000022 · wf-form4_148953077944230.xml · nonDerivative · entry 3 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,935 F2 · shares: This sale is pursuant to a 10b5-1 Trading Plan that was established on February 9, 2017. F1 · balance_after: Ownership includes 78,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 27, 2017 Filed Mar 14, 2017 22:33 UTC | CENTENE CORP CNC · Entity 3133 | GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-17-000022 · wf-form4_148953077944230.xml · nonDerivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,935 F1 · balance_after: Ownership includes 78,334 shares of restricted stock units subject to vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.